TrialRMD open2025

Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study.

Rene Westhovens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.